Alendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis

Alendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis

Treatment with glucocorticoids is associated with bone loss starting soon after therapy is initiated and an increased risk of fracture.We performed a randomized, double-placebo, double-blind clinical trial of 18 months' duration among patients with a rheumatic disease who were starting glucocor...

Fuld beskrivelse

Saved in:
Bibliografiske detaljer
Main Authors: R. N. J. de Nijs, Johannes W. G. Jacobs, Willem F. Lems, Roland Laan, Ale Algra, Anne-Margriet Huisman, Erik Buskens, Chris De Laet, A. Oostveen, Piet Geusens, George A. W. Bruyn, Ben A. C. Dijkmans, J. W. J. Bijlsma
Format: Artigo
Sprog:engelsk
Udgivet: 2006
Online adgang:https://doi.org/10.1056/nejmoa053569
https://www.nejm.org/doi/pdf/10.1056/NEJMoa053569?articleTools=true
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
Vær først til at give en kommentarø!
Du skal først være logget ind

Lignende værker